Insider Trading Alert - CHRW, MDSO And XEC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Aug. 25, 2014, 97 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $508.38 to $15,061,515.27.

Highlighted Stocks Traded by Insiders:

CH Robinson Worldwide (CHRW) - FREE Research Report

Campbell Ben G, who is VP-General Counsel & Secretary at CH Robinson Worldwide, sold 700 shares at $68.66 on Aug. 25, 2014. Following this transaction, the VP-General Counsel & Secretary owned 36,914 shares meaning that the stake was reduced by 1.86% with the 700-share transaction.

The shares most recently traded at $68.36, down $0.30, or 0.44% since the insider transaction. Historical insider transactions for CH Robinson Worldwide go as follows:

  • 4-Week # shares bought: 400
  • 4-Week # shares sold: 35,512
  • 12-Week # shares bought: 400
  • 12-Week # shares sold: 40,844
  • 24-Week # shares bought: 400
  • 24-Week # shares sold: 41,544

The average volume for CH Robinson Worldwide has been 1.6 million shares per day over the past 30 days. CH Robinson Worldwide has a market cap of $10.1 billion and is part of the services sector and transportation industry. Shares are up 17.5% year-to-date as of the close of trading on Monday.

C.H. Robinson Worldwide, Inc., a third party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide. The stock currently has a dividend yield of 2.05%. The company has a P/E ratio of 25.0. Currently, there are 2 analysts who rate CH Robinson Worldwide a buy, 3 analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHRW - FREE

TheStreet Quant Ratings rates CH Robinson Worldwide as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in stock price during the past year and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CH Robinson Worldwide Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Medidata Solutions (MDSO) - FREE Research Report

Hirschfeld Steven Isaac, who is EVP- Customer Operations at Medidata Solutions, sold 23,801 shares at $44.00 on Aug. 25, 2014. Following this transaction, the EVP- Customer Operations owned 68,488 shares meaning that the stake was reduced by 25.79% with the 23,801-share transaction.

The shares most recently traded at $44.91, up $0.91, or 2.02% since the insider transaction. Historical insider transactions for Medidata Solutions go as follows:

  • 4-Week # shares sold: 74,655
  • 12-Week # shares sold: 154,655
  • 24-Week # shares sold: 254,655

The average volume for Medidata Solutions has been 551,000 shares per day over the past 30 days. Medidata Solutions has a market cap of $2.4 billion and is part of the technology sector and computer software & services industry. Shares are down 26.13% year-to-date as of the close of trading on Monday.

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences in the United States and internationally. The company has a P/E ratio of 367.2. Currently, there are 9 analysts who rate Medidata Solutions a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDSO - FREE

TheStreet Quant Ratings rates Medidata Solutions as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and premium valuation. Get the full Medidata Solutions Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cimarex Energy (XEC) - FREE Research Report

Korus Paul, who is Sr Vice Pres, CFO at Cimarex Energy, sold 5,000 shares at $139.02 on Aug. 25, 2014. Following this transaction, the Sr Vice Pres, CFO owned 124,712 shares meaning that the stake was reduced by 3.85% with the 5,000-share transaction.

The shares most recently traded at $142.33, up $3.31, or 2.33% since the insider transaction. Historical insider transactions for Cimarex Energy go as follows:

  • 4-Week # shares sold: 3,600
  • 12-Week # shares sold: 10,038
  • 24-Week # shares sold: 20,855

The average volume for Cimarex Energy has been 1.3 million shares per day over the past 30 days. Cimarex Energy has a market cap of $11.7 billion and is part of the basic materials sector and energy industry. Shares are up 32.63% year-to-date as of the close of trading on Monday.

Cimarex Energy Co. operates as an independent oil and gas exploration and production company primarily in Texas, Oklahoma, and New Mexico. The company owns interests in 4,160 net productive oil and gas wells. The stock currently has a dividend yield of 0.47%. The company has a P/E ratio of 20.7. Currently, there are 16 analysts who rate Cimarex Energy a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XEC - FREE

TheStreet Quant Ratings rates Cimarex Energy as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Cimarex Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again